CClinicalTrials.gg
TerminatedNCT00387439Updated Sep 19, 2013

ORALIA Trial Medical Treatment vs Anoperineal Physiotherapy for Adult Anal Incontinence.

An interventional study of standard medical treatment + anoperineal physiotherapy. and Standard medical treatment in Anal Incontinence, sponsored by Hospices Civils de Lyon. Terminated at 1 site in France. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2013-09-19.

Sponsored by Hospices Civils de Lyon · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
173
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the impact of anoperineal physiotherapy in adjunction to standard medical treatment on symptoms and quality of life of adults with anal incontinence, in comparison with standard treatment alone.

A total of 443 patients will be randomized to 2 groups: standard care (medical treatment) alone or standard care associated with anoperineal physiotherapy. Outcome measures include the patient own view of the effectiveness of the treatment, the continence score, quality of life and psychological status. These outcomes are measured at the end of the 4 months treatment period.

Following this period, the non responders to standard medical treatment will be proposed to undergo a course of anoperineal physiotherapy and the non responders to anoperineal physiotherapy will be treated by transcutaneous electrical nerve stimulation (TENS). The outcomes will be measured at the end of the 4 months new treatment and again after 4 months follow-up.

02

Conditions studied

  • Anal Incontinence

Browse trials for

Keywords

  • Anal incontinence
  • Gastroenterology
  • Anoperineal physiotherapy
  • Randomized clinical trial
03

In context

Fecal Incontinence

312 studies on the registry are indexed under Fecal Incontinence; 57 are open to participants now.

This study's enrollment of 173 is above the median of 50 across 216 interventional studies indexed under Fecal Incontinence.

Browse Fecal Incontinence studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18 to 75
  • Anal incontinence for more than six months.
  • Signed informed consent
  • Jorge and Wexner's anal incontinence score > or egal 5

Exclusion criteria

Exclusion Criteria:

  • Previous course of anoperineal physiotherapy within the past 6 months
  • Anorectal or perineal surgery within the past 6 months.
  • Indication for anoperineal surgery
  • Vaginal delivery within the past 6 months
  • Pregnancy
  • Major neurological disease,
  • Significant cognitive impairment, dementia or institutionalised.
  • Active inflammatory bowel disease.
  • Current treatment by sacral nerve neurostimulation.
  • Cardiac pacemaker
  • Skin damages preventing transcutaneous electrical nerve stimulation (TENS).
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
173 participants (actual)

Study arms

  • Experimental
    standard medical treatment

    standard medical treatment

    Behavioral: Standard medical treatment

  • Experimental
    standard medical treatment + anoperineal physiotherapy

    standard medical treatment + anoperineal physiotherapy

    Behavioral: standard medical treatment + anoperineal physiotherapy.

Interventions

  • Behavioralstandard medical treatment + anoperineal physiotherapy.
  • BehavioralStandard medical treatment
06

What researchers measure

Primary outcomes

  1. The primary outcome variable is the patient's response to the question "How would you grade your symptom": major aggravation; aggravation, no changes, improvement and major improvement and rating of that change on an ordinal scale of -5 to +5. The p

    Time frame: during the treatment period

Secondary outcomes

  1. Secondary outcomes include patient's symptoms questionnaire, continence score, quality of life questionnaire, stool diary and psychological status. These secondary outcomes are measured at the end of the 4 months treatment period and the end of follow-up

    Time frame: at the end of the 4 months treatment period and the end of follow-up

07

Study locations

1 site
  • Anne-Marie SCHOTT
    Lyon, 69424, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00387439
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Oct 13, 2006
Start date
Oct 2006
Primary completion
Jun 2011
Completion
Dec 2011
Last update
Sep 19, 2013

Study contacts

François MION, MD
principal investigator · Hospices Civils de Lyon
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion